Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy; as adjunctive therapy in the treatment of myoclonic seizures
Product details
Country of Origin | Made in India |
Form | Injection |
Manufacturer | MITS |
Brand | Levetiracetam Injection |
Prescription/Non prescription | Prescription |
Composition | Levetiracetam Injection |
![]() |
MITS HEALTHCARE PRIVATE LIMITED
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |